Scalable pipeline for local ancestry inference

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The 23Andme, Inc. patent solves the following problem:

Ancestry deconvolution aims to recognize the ancestral origin of chromosomal people. Ancestry deconvolution admixed individuals (ie, those whose ancestors as grandparents from different regions) is straightforward when the global population considered sufficient (for example, a grandfather from Europe and one from Asia). To date, however, current methods are often not effective in distinguishing between closely related populations (eg, in Europe). Furthermore, because of their computational complexity, the current procedures for background deconvolution not good for application in setting large-scale, which references ornaments used include thousands of people.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 9213947 B1 deals with Scalable pipeline for local ancestry inference.
Ancestry deconvolution includes gain unphased genotype data in an individual; destroy, to use one or more processors, unphased genotype data creation of haplotype data; Using a machine learning to classify the portion of lost data haplotype as equivalent in certain ancestries individuals and create initial classification results; and correction of errors in the classification results in the creation of modified classification results.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Specimen sample collection system

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Oasis Diagnostics, Corporation patent solves the following problem:

Over the last few years there was a large increase in area of ​​salivary diagnostics, prompted in part by efforts from the National Institutes of Health (NIH) and the National Institute of Dental and Craniofacial Research (NIDCR) division to improve development of non-invasive technology for the diagnosis of disease and to measure specific analytes or molecules in saliva or oral fluid sample. These agencies make funds available for the development of novel, innovative tools including microarrays, lab-on-a-chip, lateral flow, ELISA and other technologies to use saliva and other non- invasive sampling method. Some reasons for the increased interest in salivary diagnostics involves the development of important new technologies for the collection and testing of oral fluids and improvements in the manufacturability of such devices.

Our analysis of this patent is as follows:

Oasis Diagnostics, Corporation’s patent US 9198641 B2 deals with Specimen sample collection system.
A specimen sample collection system includes a handle having opposed first and second ends, and a sufficient sign with the shaft, wherein the second end management and sufficiency indicator of a hole adapted to receive a sample collection pad; a sample collection pad with opposing ends, the sample collection pad partially within and extending from the direction of the second end, and in contact with enough evidence, the sample collection pad with a cylindrical cross section; and, in a pad compression tube having a first open end to go over the sample collection pad and the second end of the handle, an opposing second end, an inner surface extending therebetween, and at least outlet port proximal to the pad compression tube second end and in fluid communication with the pad compression tube inside. The system may include where sufficient evidence is a light pipe, or other elements that showed, providing visual, aural or haptic indication of sufficient sample volume. The system may include where sufficient evidence includes longitudinal channel extending along the inner surface in contact with the sample collection pad to provide a way for displacement air. The system may include a sealing member to seal against a pad compression tube and perform specimen collection pad. The system may include one or more collection tubes attachable to one or more of the pad compression tube outlet port. The system may include ergonomic portion of the rod and pad compression tube. The system may include a specimen collection pad with a whole cross section of a reduced cross section portion, including a shoulder making a sealing member and an angled face to conform to the inner surface of a light pipe sufficiency indicator. The system may include one or more in-line filter next to the pad compression tube outlet port. The system may include additional features as described herein.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Multi compartment body part scraping fluid collection device

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Oasis Diagnostics Corp. patent solves the following problem:

Over the last few years there was a large increase in area of ​​salivary diagnostics, prompted in part by efforts from the National Institutes of Health (NIH) and the National Institute of Dental and Craniofacial Research (NIDCR) division to improve development of non-invasive technology for the diagnosis of disease and to measure specific analytes or molecules in saliva or oral fluid sample. These agencies make funds available for the development of novel, innovative tools including microarrays, lab-on-a-chip, lateral flow, ELISA and other technologies to use saliva and other non- invasive sampling method. Some reasons for the increased interest in salivary diagnostics involves the development of important new technologies for the collection and testing of oral fluids and improvements in the manufacturability of such devices.

Our analysis of this patent is as follows:

Oasis Diagnostics Corp.’s patent US 8551016 B2 deals with Multi compartment body part scraping fluid collection device.
A picture is a fluid sample collection system. More specifically, a picture is a fluid sample collection system to facilitate collection of biological specimens and especially to facilitate the collection of saliva, urine, and stool specimens from humans or animals for the purpose of obtaining pure DNA and / or RNA.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Gamete donor selection based on genetic calculations

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The 23Andme, Inc. patent solves the following problem:

Gamete storage facilities like a seed / egg bank making more people have greater control and more choice in reproduction. At present, some facilities in collecting the sperm or egg donation as well as certain profile information about the donors. Such information generally includes the donor race, height, weight, age, blood type, health condition, eye color, educational background, family history, and with a potential recipient can review the profile and make a choice. Although the personal profiles of donors can serve a useful purpose for the potential recipient to make a better choice, the information is usually offered only limited understanding for recipients with specific concerns about certain genetic traits, such as hereditary diseases, to make a truly informed choice. For example, a recipient of a family history of breast cancer may worry about receiving a donation from a man who was also a high risk group; however, if the family history information is incomplete or unavailable, have not been able to make an informed choice.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8543339 B2 deals with Gamete donor selection based on genetic calculations.
Gamete donor selection includes receiving a call including a phenotype of interest, accepting a genotype one receiving a plurality of genotypes in a respective plurality of donors, determine statistical information about the phenotype of interest based at least in part to different pairings genotype recipient and a genotype of a donor plurality of donors, and the recognition of a donor among the plurality of donors, based at least in part on statistical information determined.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.